Veterinary Medicines

Calfoset raztopina za injiciranje za konje, govedo, prašiče, ovce in koze

Authorised
  • Calcium gluconate
  • CALCIUM GLYCEROPHOSPHATE
  • Magnesium chloride hexahydrate
Download as PDF

Product identification

Medicine name:
Calfoset raztopina za injiciranje za konje, govedo, prašiče, ovce in koze
Active substance:
  • Calcium gluconate
  • CALCIUM GLYCEROPHOSPHATE
  • Magnesium chloride hexahydrate
Target species:
  • Horse
  • Cattle
  • Sheep
  • Goat
  • Pig (sow)
  • Pig
Route of administration:
  • Intravenous use
  • Intramuscular use
  • Subcutaneous use

Product details

Active substance and strength:
  • Calcium gluconate
    32.82
    gram(s)
    /
    100.00
    millilitre(s)
  • CALCIUM GLYCEROPHOSPHATE
    8.13
    gram(s)
    /
    100.00
    millilitre(s)
  • Magnesium chloride hexahydrate
    4.18
    gram(s)
    /
    100.00
    millilitre(s)
Pharmaceutical form:
  • Solution for injection
Withdrawal period by route of administration:
  • Intravenous use
    • Horse
      • Meat and offal, milk
        0
        day
    • Cattle
      • Meat and offal, milk
        0
        day
    • Sheep
      • Meat and offal, milk
        0
        day
    • Goat
      • Meat and offal, milk
        0
        day
    • Pig (sow)
      • Meat and offal
        0
        day
  • Intramuscular use
    • Cattle
      • Meat and offal, milk
        0
        day
    • Sheep
      • Meat and offal, milk
        0
        day
    • Goat
      • Meat and offal, milk
        0
        day
    • Pig
      • Meat and offal
        0
        day
  • Subcutaneous use
    • Cattle
      • Meat and offal, milk
        0
        day
    • Sheep
      • Meat and offal, milk
        0
        day
    • Goat
      • Meat and offal, milk
        0
        day
    • Pig
      • Meat and offal
        0
        day
Anatomical therapeutic chemical veterinary (ATCvet) codes:
  • QA12AX
Legal status of supply:
  • Veterinary medicinal product subject to veterinary prescription
Authorisation status:
  • Valid
Authorised in:
  • Slovenia
Package description:

Additional information

Entitlement type:
  • Marketing Authorisation
Legal basis of product authorisation:
  • Legal basis not covered by Directive 2001/82/EC
Marketing authorisation holder:
  • KRKA tovarna zdravil d.d. Novo mesto
Marketing authorisation date:
Manufacturing sites for batch release:
  • KRKA tovarna zdravil d.d. Novo mesto
Responsible authority:
  • Agency For Medicinal Products And Medical Devices Of The Republic Of Slovenia
Authorisation number:
  • NP/V/0056/001
Date of authorisation status change:

Documents

Summary of Product Characteristics

This document does not exist in this language (English). You can find it in another language below.
Slovenian (PDF)
Published on: 5/11/2021
Download

Package Leaflet

This document does not exist in this language (English). You can find it in another language below.
Slovenian (PDF)
Published on: 5/11/2021
Download

Labelling

This document does not exist in this language (English). You can find it in another language below.
Slovenian (PDF)
Published on: 5/11/2021
Download
How useful was this page?:
No votes yet
"Please do not include any personal data, such as your name or contact details. If you do, you consent to the processing of that data in accordance with EMA’s Privacy Statement concerning requests for information or access to documents. If you would like a reply from EMA, please Send a question to EMA instead."